Skip to main content
    M

    MBX Biosciences, Inc. Common Stock (MBX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $53.10
    -0.02 (-0.04%)

    Market Cap: $2.64B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    MBX Biosciences, Inc. Common Stock (MBX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    MBX Biosciences, Inc. Common Stock (MBX) has a market cap of $2.64B and an enterprise value of $2.48B. Its share count is up 41.99% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 6.13% below the market cap, as cash exceeds debt.

    Market Cap$2.64B
    Enterprise Value$2.48B
    Latest price (Nov 17, 2026)$53.10

    Key Dates

    The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 10, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.81% in the quarter ended Sep 30, 2026 and grew 173.00% a year over 2 years.

    Shares Outstanding48.56M
    Shares Change (YoY)+41.99%
    Shares Change (QoQ)+1.81%
    Share Count Growth (2Y CAGR)+173.00%

    Price Statistics

    The stock is up 114.20% over 52 weeks and trades 4.17% below its 50-day average.

    Beta (1Y)1.31
    52-Week Change+114.20%
    1-Month Change+1.18%
    3-Month Change-22.37%
    6-Month Change+74.73%
    Total Return (1Y)+114.20%
    Return vs SPY (1Y)+89.88%
    Max Drawdown (1Y)-37.60%
    Max Drawdown (3Y)-77.71%
    Sharpe Ratio (1Y)0.93
    Correlation with SPY (1Y)0.24
    50-Day Average$55.41
    200-Day Average$46.48
    52-Week Range$26.00 to $72.64
    RSI (14 Days)47.9
    Average Volume (20 Days)508.44K

    Price chart

    Financial Position

    Current assets cover 19.58x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio19.58x
    Quick Ratio19.58x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -30.68% and return on assets is -28.98% over the last 12 months.

    Return on Equity (ROE)-30.68%
    Return on Assets (ROA)-28.98%

    Scores

    MBX has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$60.00K
    Operating Income-$160.33M
    Pretax Income-$145.09M
    Net Income-$145.09M
    Reported EPS (TTM)-$3.07

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 94.47% of the $500.62M in total assets.

    Cash and Equivalents$161.69M
    Total Debt$0
    Net Cash$161.69M
    Net Cash Per Share$3.33
    Working Capital$467.60M
    Shareholder Equity$472.95M
    Book Value Per Share$9.74
    Total Assets$500.62M
    Total Liabilities$27.67M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $3.32M of capital spending, operating cash flow left -$99.33M of free cash flow.

    Operating Cash Flow-$96.01M
    Capital Expenditures$3.32M
    Free Cash Flow-$99.33M
    FCF Per Share-$2.06
    Depreciation and Amortization$2.10M
    Share Repurchases$1.05M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    MBX does not pay a dividend. Its free cash flow yield is -3.85%.

    FCF Yield-3.85%
    Buyback Yield-7.05%
    Shareholder Yield-7.05%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About MBX

    What is MBX's market cap?

    MBX Biosciences, Inc. Common Stock has a market cap of $2.64B. Its enterprise value, which adds debt and subtracts cash, is $2.48B.

    How many shares of MBX are outstanding?

    MBX Biosciences, Inc. Common Stock has 48.56M shares outstanding. The count is up 41.99% from a year earlier.

    Does MBX pay a dividend?

    No. MBX Biosciences, Inc. Common Stock does not pay a dividend.

    How much debt does MBX have?

    MBX Biosciences, Inc. Common Stock has $0 of total debt and $161.69M of cash and equivalents, a net cash position of $161.69M.